Shots:
- In this captivating episode of the CXO Talks Podcast, PharmaShots sits down with Josh Wittner, President, North America at Gene By Gene, to explore the company’s evolution and impact in the field of genetic testing
- Gene By Gene, a leading commercial genetic testing company, delivers cutting-edge genetic data services spanning a broad range of microarray and sequencing technologies
- Josh shares insights into the company’s transformative journey, from myDNA’s merger to strategic collaborations with Ultima Genomics and Living Laboratories, shaping the future of precision medicine
About the Author
Josh Wittner
Josh Wittner has been instrumental in driving Gene By Gene’s remarkable growth in Next Generation Sequencing (NGS). With a focus on leveraging cutting-edge technology to advance patient care and research, he has demonstrated exceptional leadership and strategic vision. Under his guidance, Gene By Gene has strengthened its commercial success and established itself as a global leader in genetic testing services.
Related Post: CXO Talks: Rick Modi from Affinia Therapeutics in a Stirring Dialogue Exchange with PharmaShots
